UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

No Difference of Adalimumab Pharmacokinetics When Dosed at 40 mg Every Week or 80 mg Every Other Week in IBD Patients in Clinical Remission After Adalimumab Dose Intensification

Digestive diseases and sciences, 2021-08, Vol.66 (8), p.2744-2749

2021

Volltextzugriff (PDF)

Early venous thromboembolism is a strong prognostic factor in patients with advanced pancreatic ductal adenocarcinoma

Journal of cancer research and clinical oncology, 2021-11, Vol.147 (11), p.3447-3454

2021

Volltextzugriff (PDF)

Gastric Pneumatosis with Portal Venous Gas can be Treated Non-operatively: A Retrospective Multi-institutional Study

World journal of surgery, 2022-04, Vol.46 (4), p.784-790

2022

Volltextzugriff (PDF)

Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: A large multicenter AGEO study

Journal of hepatology, 2013-01, Vol.58 (1), p.81-88

2013

Volltextzugriff (PDF)

Diagnostic accuracy of updated International versus European guidelines for resection of Intraductal papillary mucinous neoplasm: Is it a draw?

Digestive and liver disease, 2021-08, Vol.53 (8), p.996-997

Williet, Nicolas

2021

Volltextzugriff (PDF)

Golimumab pharmacokinetics in ulcerative colitis: a literature review

Therapeutic Advances in Gastroenterology, 2017-01, Vol.10 (1), p.89-100

2017

Volltextzugriff (PDF)

Trend towards dose reduction of azathioprine as monotherapy in inflammatory bowel disease patients: what about for combination therapy?

Therapeutic advances in gastroenterology, 2017-01, Vol.10 (1), p.5-10

2017

Volltextzugriff (PDF)

Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review

The American journal of clinical nutrition, 2015-12, Vol.102 (6), p.1585-1594

2015

Volltextzugriff (PDF)

Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study

Therapeutic advances in gastroenterology, 2019, Vol.12, p.1756284819878660-1756284819878660

2019

Volltextzugriff (PDF)

Safety and efficacy of emergency transarterial embolization for mesenteric bleeding

CVIR endovascular, 2022-01, Vol.5 (1), p.5-5, Article 5

2022

Volltextzugriff (PDF)

Cancers localement avancés du pancréas : une hétérogénéité de situations à bien saisir

Hépato-gastro & oncologie digestive, 2022-04, Vol.29 (4), p.452-461

2022

Volltextzugriff (PDF)

Serum calprotectin is useful to confirm inflammatory bowel disease activity but not to predict relapse

Clinical immunology communications, 2022-12, Vol.2, p.33-38

2022

Volltextzugriff (PDF)

Submucosal plexitis as a predictor of postoperative surgical recurrence in Crohn's disease

Inflammatory bowel diseases, 2013-07, Vol.19 (8), p.1654-1661

2013

Volltextzugriff (PDF)

The Simplified Magnetic Resonance Index of Activity (MARIA) for Crohn’s Disease Is Strongly Correlated With the MARIA and Clermont Score: An External Validation

Gastroenterology (New York, N.Y. 1943), 2020-01, Vol.158 (1), p.282-283

2020

Volltextzugriff (PDF)

First Characterization with Ultrasound Contrast Agent of a Fibrovascular Polyp Before Its Endoscopic Resection: A Case Report (with Videos)

Clinical Endoscopy, 2019, 52(2), , pp.186-190

2019

Volltextzugriff (PDF)

Patient-Reported Outcomes as Primary End Points in Clinical Trials of Inflammatory Bowel Disease

Clinical gastroenterology and hepatology, 2014-08, Vol.12 (8), p.1246-1256.e6

2014

Volltextzugriff (PDF)

Neoadjuvant sorafenib combined with gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma

World journal of gastroenterology : WJG, 2011-05, Vol.17 (17), p.2255-2258

2011

Volltextzugriff (PDF)

Sa1894 IN FAILURE OF NON-OPTIMIZED ADALIMUMAB (ADA) WITH THERAPEUTIC SERUM LEVELS, A CHANGE OF BIOTHERAPY CLASS IS GREATER THAN AN INTENSIFICATION OF ADA IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS I

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-469-S-469

2020

Volltextzugriff (PDF)

Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial

Gut, 2020-07, Vol.69 (7), p.1206-1212

2020

Volltextzugriff (PDF)

Patient-reported Outcomes in a French Nationwide Survey of Inflammatory Bowel Disease Patients

Journal of Crohn's and colitis, 2017-02, Vol.11 (2), p.165-174

2017

Volltextzugriff (PDF)

Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease

Gut, 2011-07, Vol.60 (7), p.930-936

2011

Volltextzugriff (PDF)

Association Between Low Trough Levels of Vedolizumab During Induction Therapy for Inflammatory Bowel Diseases and Need for Additional Doses Within 6 Months

Clinical gastroenterology and hepatology, 2017-11, Vol.15 (11), p.1750-1757.e3

2017

Volltextzugriff (PDF)

Impact of the Duration of Combination Therapy on Clinical and Pharmacological Efficacy of Infliximab in Inflammatory Bowel Diseases

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S395-S395

2017

Volltextzugriff (PDF)

Sa1926 - Impact of the Duration of Combination Therapy on Clinical and Pharmacological Efficacy of Infliximab in Inflammatory Bowel Diseases

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S395-S395

2017

Volltextzugriff (PDF)

Effect of Endocuff-assisted colonoscopy on adenoma detection rate: meta-analysis of randomized controlled trials

Endoscopy, 2018-09, Vol.50 (9), p.846-860

2018

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(85)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(71)
Science & Technology
(71)
Gastroenterology & Hepatology
(46)
Humans
(45)
Life Sciences
(26)
Male
(26)
Female
(25)
Adult
(19)
Middle Aged
(18)
Surgery
(18)
Oncology
(17)
Chemotherapy
(13)
Cancer
(12)
Patients
(12)
Aged
(11)
Inflammatory Bowel Disease
(11)
Inflammatory Bowel Diseases - Drug Therapy
(11)
Prognosis
(11)
Retrospective Studies
(10)
Survival
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

No Difference of Adalimumab Pharmacokinetics When Dosed at 40 mg Every Week or 80 mg Every Other Week in IBD Patients in Clinical Remission After Adalimumab Dose Intensification

Early venous thromboembolism is a strong prognostic factor in patients with advanced pancreatic ductal adenocarcinoma

Gastric Pneumatosis with Portal Venous Gas can be Treated Non-operatively: A Retrospective Multi-institutional Study

Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: A large multicenter AGEO study

Diagnostic accuracy of updated International versus European guidelines for resection of Intraductal papillary mucinous neoplasm: Is it a draw?

Golimumab pharmacokinetics in ulcerative colitis: a literature review

Trend towards dose reduction of azathioprine as monotherapy in inflammatory bowel disease patients: what about for combination therapy?

Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review

Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study

Safety and efficacy of emergency transarterial embolization for mesenteric bleeding

Cancers localement avancés du pancréas : une hétérogénéité de situations à bien saisir

Serum calprotectin is useful to confirm inflammatory bowel disease activity but not to predict relapse

Submucosal plexitis as a predictor of postoperative surgical recurrence in Crohn's disease

The Simplified Magnetic Resonance Index of Activity (MARIA) for Crohn’s Disease Is Strongly Correlated With the MARIA and Clermont Score: An External Validation

First Characterization with Ultrasound Contrast Agent of a Fibrovascular Polyp Before Its Endoscopic Resection: A Case Report (with Videos)

Patient-Reported Outcomes as Primary End Points in Clinical Trials of Inflammatory Bowel Disease

Neoadjuvant sorafenib combined with gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma

Sa1894 IN FAILURE OF NON-OPTIMIZED ADALIMUMAB (ADA) WITH THERAPEUTIC SERUM LEVELS, A CHANGE OF BIOTHERAPY CLASS IS GREATER THAN AN INTENSIFICATION OF ADA IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS I

Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial

Patient-reported Outcomes in a French Nationwide Survey of Inflammatory Bowel Disease Patients

Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease

Association Between Low Trough Levels of Vedolizumab During Induction Therapy for Inflammatory Bowel Diseases and Need for Additional Doses Within 6 Months

Impact of the Duration of Combination Therapy on Clinical and Pharmacological Efficacy of Infliximab in Inflammatory Bowel Diseases

Sa1926 - Impact of the Duration of Combination Therapy on Clinical and Pharmacological Efficacy of Infliximab in Inflammatory Bowel Diseases

Effect of Endocuff-assisted colonoscopy on adenoma detection rate: meta-analysis of randomized controlled trials

Suchergebnisse filtern